Basic Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Nov 14, 2017; 23(42): 7541-7550
Published online Nov 14, 2017. doi: 10.3748/wjg.v23.i42.7541
Table 1 Relationship between clinicopathological characteristics of gastric cancer patients and nuclear heat shock protein 110 expression n (%)
FactorsHSP110 expression in gastric cancer patients (n = 14)
Low (n = 5)High (n = 9)P value
Age (mean ± SE)55.2 ± 3.859.3 ± 2.80.4025
Sex,
Male2 (22.2)7 (77.8)0.1575
Female3 (60.0)2 (40.0)
Histology
Well, Moderate1 (33.3)2 (66.7)0.9227
Muc, Poor, Signet4 (36.4)7 (63.6)
Depth
sm, mp, ss0 (0.0)0 (0.0)
se, si5 (35.7)9 (64.3)
Lymph node metastasis
Absent0 (0.0)2 (100.0)0.2549
Present5 (41.7)7 (58.3)
Lymphatic invasion
Absent1 (33.3)3 (66.7)0.4797
Present4 (40.0)6 (60.0)
Venous invasion
Absent4 (40.0)6 (60.0)0.5967
Present1 (25.0)3 (75.0)
Peritoneal lavage cytology
Negative1 (25.0)3 (75.0)0.5967
Positive4 (40.0)6 (60.0)
Peritoneal metastasis
Absent2 (50.0)2 (50.0)0.4805
Present3 (30.0)7 (70.0)
Table 2 Univariate analyses of clinicopathological features affecting progression-free survival rates in patients after surgery
Clinicopathological variablesUnivariate analysis
RR95%CIP value
Age (< 65 yr/≥ 65 yr)2.170.46-8.330.2988
Sex (male/female)1.620.48-6.220.4412
Histology (differentiated/undifferentiated)2.180.46-8.330.2988
Lymph node metastasis (absent/present)1.250.19-5.020.7822
Lymphatic invasion (absent/present)1.290.33-4.290.6904
Venous invasion (absent/present)1.180.26-4.130.8057
Peritoneal lavage cytology (negative/positive)1.320.38-6.100.6766
Peritoneal metastasis (absent/present)2.280.58-15.080.2568
HSP110 expression (low/high)3.400.94-16.010.0625